Search

for
Search:

Research

5 / 1000+ results

research A(1-7) reduces pathologies associated with SLE in MRL-lpr mice

May 2018 in “The Journal of Immunology”

In this study, daily treatment with angiotensin (1-7) significantly reduced disease severity in a mouse model of Systemic Lupus Erythematosus, suggesting potential for Mas agonists in future therapies.

research Nanocarriers for Improved Delivery of Angiotensin-(1-7)

January 2015 in “Elsevier eBooks”

This chapter reviews the use of liposomes and cyclodextrins to improve the delivery and effectiveness of the peptide angiotensin-(1-7) in various therapeutic applications and reports no new experimental results.

research 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes

56 citations , March 2003 in “Journal of Investigative Dermatology”

This study found that 17β-estradiol inhibited RANTES production in human keratinocytes by suppressing nuclear factor κB activity, suggesting a potential mechanism for 17β-estradiol's modulation of psoriasis-related inflammation.

IL-17-Producing Gamma Delta T Cells Enhance Bone Regeneration

research IL-17-producing γδ T cells enhance bone regeneration

343 citations , March 2016 in “Nature Communications”

This study found that IL-17A-producing γδ T cells play a key role in bone fracture healing by promoting bone formation, with deficiencies leading to impaired repair in mice.

Anti-TNF Antibody-Induced Psoriasiform Skin Lesions in Patients with Inflammatory Bowel Disease Are Characterised by Interferon-γ-Expressing Th1 Cells and IL-17A/IL-22-Expressing Th17 Cells and Respond to Anti-IL-12/IL-23 Antibody Treatment

research Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

278 citations , March 2013 in “Gut”

In this study, nearly 5% of anti-TNF-treated patients with IBD developed psoriasiform skin lesions, with smoking identified as a main risk factor, and ustekinumab proved highly effective in severe cases.

View more "a 1-7" in research →

Community Join

5 / 1000+ results

community 17M - beat the norwood reaper in 4 months. Am I a hyper responder? Can I maintain for a year until I can start fin?

in Progress Pictures 725 upvotes 1 year ago

A 17-year-old improved his hairline using minoxidil and derma stamping, planning to start finasteride at 18. He received advice on dosing and potential side effects to maintain results.

community Month 1 to 7 progression oral fin topical min

21 upvotes 2 months ago

The user is experiencing underwhelming hair regrowth results from using oral finasteride and topical minoxidil, considering switching to dutasteride and oral minoxidil. They stopped microneedling and tretinoin, which might have affected progress.

community One year on oral fin and 7 months on oral min at 17 years old

in Progress Pictures 18 upvotes 5 months ago

A 17-year-old started using 1mg oral finasteride in April 2025 and increased oral minoxidil from 1.25mg to 2.5mg by December 2025. Users discuss progress, initial shedding, and suggest checking vitamin and mineral levels.

community Finasteride to Dutasteride 6 months teenager 17M AMA

312 upvotes 1 year ago

A 17-year-old is using oral dutasteride, finasteride, and topical minoxidil for hair loss, with plans to increase dutasteride and consider surgery. They report significant regrowth but are worried about side effects and the effects of blocking DHT at a young age.

community Age :-17 ,on topical fin and min

in Is this regrowth? 194 upvotes 1 year ago

A 17-year-old is using topical finasteride and minoxidil for hair regrowth. The effectiveness of these treatments is discussed, with some users noting progress and others suggesting more time is needed for significant results.

View more "a 1-7" in community →